Search results

  1. V.R.T.

    Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies... 2025 Ariza et al

    Is it possible that these antibodies are a) pathogenic and b) killed by dara but not rituximab (i.e. anti cd38 but not anti cd20)?
  2. V.R.T.

    Covid-19 vaccination experiences

    Is there currently any way to get an up to date novavax shot in the UK?
  3. V.R.T.

    Trial Report Plasma cell targeting with the anti-CD38 antibody daratumumab in ME/CFS -a clinical pilot study, 2025, Fluge et al

    The thing I'm currently feeling trepidation about is the upcoming severe patient case study. If the severe patients with higher NK cells don't respond I'm going to find that difficult to cope with. Of course a handful of unblinded patients isn't exactly definitive proof but if they react like...
  4. V.R.T.

    Hypotheses and Research Directions for ME/CFS

    Ah right, I think this question was saying could PEM be caused by different things, rather than PEM causes different subtypes of symptoms. As to what you said yes I think were in agreement.
  5. V.R.T.

    Hypotheses and Research Directions for ME/CFS

    Can you explain why you think this? I'm not sure what makes this more likely than there being a single upstream cause of ME/PEM. I'm not dismissing the possibility here, I'm just interested in your reasoning.
  6. V.R.T.

    Hypotheses and Research Directions for ME/CFS

    In terms of hypothesis I'm pretty convinced by the idea of an immune signalling loop perpetuating ME/CFS. In terms of specifics I'm not really qualified to judge but I find the idea of JE et al's T cell and IFNg mediated hypothesis, jnmaciuch's interferon/mtDNA hypothesis, and the idea of some...
  7. V.R.T.

    Oliver Sacks Put Himself Into His Case Studies. What Was the Cost?

    I saw it quoted on Bluesky the other day iirc. I think it was a screenshot of a twitter post. Pinker sharing an article about 'patient activists' harassing CFS researchers etc. If I find it again I'll link it.
  8. V.R.T.

    Oliver Sacks Put Himself Into His Case Studies. What Was the Cost?

    Given Steven Pinker's promotion of the dangerous 'militant ME patients don't like good scientific findings' myth, I don't think he is the person to be handing out lessons in this area.
  9. V.R.T.

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    Is this study the basis of Younger's recent claims about heterogenaity in ME/CFS? Because this does not seem like nearly strong enough evidence to make the statements he's been making.
  10. V.R.T.

    Why can't good ME/CFS researchers get more funding?

    That's sort of what I'm getting at. We have good researchers in Edinburgh, good researchers in Fluge and Mella, some very good researcher members of this forum I could name. If we could get them collectively even half of Polybio's funding it would change things significantly. I just wonder if...
  11. V.R.T.

    Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation, 2025, Birch, Younger et al

    This study just shows how badly we need a much bigger whole genome sample like SequenceME
  12. V.R.T.

    Why can't good ME/CFS researchers get more funding?

    I was probably thinking of this in the Zhang thread, so I was kind of in the right ballpark!
  13. V.R.T.

    Why can't good ME/CFS researchers get more funding?

    No in fact I think he said in his hypothesis thread that therapeutic experiments might be crucial to proving or disproving it (but I've already misquoted him once lately so don't take my word for it!)
  14. V.R.T.

    A Study to Assess Anktiva in Patients With Long Covid-19. (INTERRUPT_LC)

    @Jonathan Edwards do you think Anktiva would risk revving up T cells and making things worse in a similar fashion to Checkpoint inhibitors if your T Cell hypothesis is correct?
  15. V.R.T.

    Why can't good ME/CFS researchers get more funding?

    I've said before, I think this is a false binary. We need the basic research and the clinical trials. With sufficient funding we wouldn't have to choose. Good quality research would entail doing both stuff like the anti-cd38 trials and SequenceME.
  16. V.R.T.

    News from Austria and Switzerland

    Oh, I just checked the treatments section of your hypothesis paper and you're right, you didn't. Don't know why I thought that. My mistake!
  17. V.R.T.

    Do we need a long-term actimeter study of PwME outside of treatment?

    This is a big reason why we need real clinics - they can do this sort of tracking of patients with ease. A ten year study of pwME who are not on any treatment would be confounded if an effective drug were found e.g. if dara works. You'd see a massive amount of participants drop out to try the...
  18. V.R.T.

    Whitney Dafoe Updates

    I just want to say - I feel really weird about this situation. I am so happy Whitney is talking again, and it was a really emotional thing to hear his voice. But this Leisk guy gives me so many red flags I can't even begin, and I am very worried about the perception that OMF supports JL leading...
  19. V.R.T.

    Why can't good ME/CFS researchers get more funding?

    Related question: is there any reason we can't aim for Polybio levels of funding for good quality ME/CFS research?
Back
Top Bottom